Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Panic Disorder | 78 | 2021 | 613 | 7.350 |
Why?
|
Depressive Disorder | 133 | 2011 | 3728 | 3.680 |
Why?
|
Fluoxetine | 75 | 2007 | 733 | 3.580 |
Why?
|
Anxiety Disorders | 81 | 2021 | 2720 | 3.550 |
Why?
|
Child of Impaired Parents | 26 | 2021 | 460 | 3.280 |
Why?
|
Clonazepam | 30 | 2004 | 135 | 2.070 |
Why?
|
Depressive Disorder, Major | 54 | 2021 | 4762 | 1.820 |
Why?
|
Agoraphobia | 29 | 2012 | 177 | 1.610 |
Why?
|
Phobic Disorders | 33 | 2012 | 439 | 1.510 |
Why?
|
Antidepressive Agents, Second-Generation | 25 | 2005 | 489 | 1.500 |
Why?
|
Anger | 19 | 2008 | 406 | 1.380 |
Why?
|
Antidepressive Agents | 39 | 2015 | 2897 | 1.370 |
Why?
|
Psychiatric Status Rating Scales | 96 | 2008 | 6019 | 1.190 |
Why?
|
Child Behavior Disorders | 12 | 2007 | 804 | 1.170 |
Why?
|
Temperament | 15 | 2013 | 297 | 1.160 |
Why?
|
Benzodiazepines | 18 | 2020 | 1132 | 1.150 |
Why?
|
Panic | 27 | 1991 | 103 | 1.150 |
Why?
|
Alprazolam | 24 | 2003 | 102 | 0.970 |
Why?
|
Anti-Anxiety Agents | 14 | 2020 | 397 | 0.940 |
Why?
|
Substance Withdrawal Syndrome | 15 | 2004 | 625 | 0.940 |
Why?
|
Attention Deficit and Disruptive Behavior Disorders | 10 | 2012 | 306 | 0.830 |
Why?
|
Psychotropic Drugs | 11 | 2010 | 888 | 0.800 |
Why?
|
Bipolar Disorder | 28 | 2010 | 5092 | 0.760 |
Why?
|
Hallucinogens | 1 | 2024 | 197 | 0.730 |
Why?
|
Lithium | 23 | 2015 | 596 | 0.710 |
Why?
|
Anxiety, Separation | 9 | 2010 | 86 | 0.700 |
Why?
|
Comorbidity | 59 | 2012 | 10508 | 0.690 |
Why?
|
Desipramine | 13 | 2004 | 182 | 0.680 |
Why?
|
Hypericum | 3 | 2013 | 58 | 0.600 |
Why?
|
Personality Inventory | 33 | 2010 | 1019 | 0.590 |
Why?
|
Personality Disorders | 14 | 2005 | 722 | 0.560 |
Why?
|
Child Behavior | 10 | 2007 | 847 | 0.560 |
Why?
|
Ambulatory Care | 38 | 2007 | 2775 | 0.540 |
Why?
|
Imipramine | 15 | 1997 | 98 | 0.530 |
Why?
|
Fear | 19 | 2004 | 1477 | 0.520 |
Why?
|
Double-Blind Method | 54 | 2013 | 12341 | 0.490 |
Why?
|
GABA Modulators | 3 | 2000 | 109 | 0.480 |
Why?
|
Mental Disorders | 18 | 2013 | 6845 | 0.480 |
Why?
|
Antidepressive Agents, Tricyclic | 12 | 2004 | 432 | 0.480 |
Why?
|
Personality Assessment | 16 | 2010 | 650 | 0.470 |
Why?
|
Expressed Emotion | 4 | 2007 | 92 | 0.470 |
Why?
|
Phytotherapy | 3 | 2013 | 296 | 0.450 |
Why?
|
Personality Development | 11 | 2003 | 244 | 0.430 |
Why?
|
Adult | 219 | 2021 | 221210 | 0.430 |
Why?
|
Cyclohexanols | 3 | 2000 | 126 | 0.430 |
Why?
|
Research Design | 15 | 2024 | 6180 | 0.430 |
Why?
|
Hostility | 8 | 2008 | 183 | 0.420 |
Why?
|
Psychopharmacology | 4 | 2005 | 148 | 0.420 |
Why?
|
Anxiety | 13 | 2015 | 4573 | 0.410 |
Why?
|
Pregnancy Complications | 9 | 2004 | 2947 | 0.410 |
Why?
|
Humans | 336 | 2024 | 761596 | 0.400 |
Why?
|
Adolescent Psychiatry | 1 | 2013 | 157 | 0.390 |
Why?
|
Female | 245 | 2015 | 392705 | 0.390 |
Why?
|
Placebos | 20 | 2004 | 1667 | 0.390 |
Why?
|
Drug Administration Schedule | 34 | 2007 | 4853 | 0.380 |
Why?
|
1-Naphthylamine | 5 | 1998 | 49 | 0.380 |
Why?
|
Male | 224 | 2015 | 360846 | 0.370 |
Why?
|
Substance-Related Disorders | 11 | 2013 | 4420 | 0.370 |
Why?
|
Clinical Trials as Topic | 21 | 2008 | 8002 | 0.360 |
Why?
|
Social Adjustment | 9 | 2007 | 632 | 0.360 |
Why?
|
Psychiatry | 6 | 2009 | 1693 | 0.360 |
Why?
|
Mood Disorders | 4 | 2010 | 1127 | 0.340 |
Why?
|
Severity of Illness Index | 35 | 2007 | 15843 | 0.330 |
Why?
|
Puerperal Disorders | 4 | 1995 | 300 | 0.310 |
Why?
|
Adolescent | 85 | 2021 | 88326 | 0.300 |
Why?
|
S-Adenosylmethionine | 7 | 1999 | 218 | 0.290 |
Why?
|
Shyness | 5 | 2004 | 21 | 0.290 |
Why?
|
Treatment Outcome | 79 | 2013 | 64685 | 0.280 |
Why?
|
Commitment of Mentally Ill | 1 | 2007 | 94 | 0.280 |
Why?
|
Sexual Dysfunctions, Psychological | 4 | 2002 | 189 | 0.280 |
Why?
|
Dose-Response Relationship, Drug | 28 | 2004 | 10766 | 0.280 |
Why?
|
Child | 58 | 2021 | 80158 | 0.270 |
Why?
|
Thyrotropin | 7 | 1996 | 834 | 0.270 |
Why?
|
Birth Order | 1 | 2006 | 95 | 0.270 |
Why?
|
Depression, Postpartum | 3 | 1995 | 346 | 0.260 |
Why?
|
September 11 Terrorist Attacks | 1 | 2007 | 105 | 0.260 |
Why?
|
Risk Factors | 50 | 2015 | 74213 | 0.260 |
Why?
|
Suicide, Attempted | 3 | 2010 | 1402 | 0.260 |
Why?
|
Attention | 3 | 2013 | 2396 | 0.250 |
Why?
|
Middle Aged | 141 | 2015 | 220921 | 0.250 |
Why?
|
Child, Preschool | 35 | 2021 | 42232 | 0.250 |
Why?
|
Referral and Consultation | 5 | 2006 | 3600 | 0.250 |
Why?
|
Hospitals, General | 4 | 2004 | 798 | 0.240 |
Why?
|
Age of Onset | 14 | 2006 | 3306 | 0.230 |
Why?
|
Life Change Events | 5 | 2004 | 952 | 0.230 |
Why?
|
Drug Therapy, Combination | 23 | 2006 | 6312 | 0.230 |
Why?
|
Thyrotropin-Releasing Hormone | 6 | 1996 | 139 | 0.230 |
Why?
|
Television | 1 | 2007 | 408 | 0.230 |
Why?
|
Managed Care Programs | 3 | 1998 | 940 | 0.230 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 9 | 2008 | 3708 | 0.220 |
Why?
|
Personality | 5 | 2010 | 554 | 0.220 |
Why?
|
Monoamine Oxidase Inhibitors | 7 | 2002 | 156 | 0.220 |
Why?
|
Age Factors | 14 | 2013 | 18399 | 0.220 |
Why?
|
Paroxetine | 5 | 2001 | 182 | 0.210 |
Why?
|
Patient Dropouts | 7 | 2003 | 412 | 0.210 |
Why?
|
Longitudinal Studies | 23 | 2010 | 14608 | 0.210 |
Why?
|
Hippocampus | 1 | 2015 | 3766 | 0.200 |
Why?
|
Violence | 2 | 2007 | 937 | 0.200 |
Why?
|
Follow-Up Studies | 37 | 2012 | 39106 | 0.200 |
Why?
|
Mothers | 3 | 2005 | 2198 | 0.200 |
Why?
|
Lithium Chloride | 1 | 2002 | 82 | 0.200 |
Why?
|
Prolactin | 4 | 2003 | 625 | 0.200 |
Why?
|
Social Environment | 5 | 2004 | 1020 | 0.200 |
Why?
|
Parents | 7 | 2008 | 3563 | 0.190 |
Why?
|
Bioethics | 1 | 2003 | 117 | 0.190 |
Why?
|
Fenfluramine | 2 | 2003 | 58 | 0.190 |
Why?
|
Recurrence | 21 | 2010 | 8466 | 0.180 |
Why?
|
Thymopoietins | 1 | 2000 | 10 | 0.180 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 7 | 2008 | 1988 | 0.180 |
Why?
|
Estrogen Replacement Therapy | 3 | 1999 | 1208 | 0.180 |
Why?
|
Family Health | 5 | 2007 | 1257 | 0.180 |
Why?
|
Dopamine Agonists | 2 | 2000 | 352 | 0.180 |
Why?
|
Depression | 9 | 2021 | 8126 | 0.170 |
Why?
|
Dysthymic Disorder | 2 | 1997 | 75 | 0.170 |
Why?
|
Vitamin B 12 | 4 | 2005 | 524 | 0.170 |
Why?
|
Societies, Medical | 2 | 2014 | 3905 | 0.170 |
Why?
|
Arousal | 7 | 2008 | 1166 | 0.170 |
Why?
|
Homocysteine | 4 | 2005 | 638 | 0.170 |
Why?
|
Epidemiologic Research Design | 1 | 2003 | 368 | 0.170 |
Why?
|
Aggression | 5 | 2000 | 750 | 0.170 |
Why?
|
Cerebral Cortex | 2 | 2013 | 5779 | 0.170 |
Why?
|
Prevalence | 18 | 2008 | 15733 | 0.160 |
Why?
|
Cocaine | 3 | 1991 | 958 | 0.160 |
Why?
|
Alcoholism | 4 | 2001 | 1973 | 0.160 |
Why?
|
Thiazoles | 3 | 2004 | 1517 | 0.160 |
Why?
|
Climacteric | 2 | 1999 | 57 | 0.160 |
Why?
|
Hydrocortisone | 6 | 2003 | 1819 | 0.160 |
Why?
|
Pregnancy Outcome | 3 | 2001 | 2922 | 0.160 |
Why?
|
Orgasm | 3 | 2002 | 61 | 0.160 |
Why?
|
Obsessive-Compulsive Disorder | 6 | 2012 | 1491 | 0.150 |
Why?
|
Benzodiazepinones | 3 | 1986 | 50 | 0.150 |
Why?
|
Triazoles | 1 | 2004 | 903 | 0.150 |
Why?
|
Seasonal Affective Disorder | 2 | 1995 | 49 | 0.150 |
Why?
|
Premenstrual Syndrome | 2 | 1999 | 109 | 0.150 |
Why?
|
Economics, Medical | 1 | 1998 | 112 | 0.140 |
Why?
|
Defense Mechanisms | 1 | 1998 | 180 | 0.140 |
Why?
|
Analysis of Variance | 7 | 2004 | 6228 | 0.140 |
Why?
|
Neurotic Disorders | 1 | 1997 | 77 | 0.140 |
Why?
|
Vagus Nerve | 1 | 2000 | 458 | 0.140 |
Why?
|
Sick Role | 2 | 1996 | 229 | 0.140 |
Why?
|
Bupropion | 2 | 2000 | 304 | 0.140 |
Why?
|
Tubulin | 1 | 2000 | 693 | 0.140 |
Why?
|
Dopamine Agents | 1 | 1998 | 189 | 0.140 |
Why?
|
Carbon Dioxide | 3 | 1994 | 1147 | 0.140 |
Why?
|
Sex | 1 | 1996 | 53 | 0.130 |
Why?
|
Probability | 9 | 2013 | 2477 | 0.130 |
Why?
|
Pilot Projects | 12 | 2006 | 8633 | 0.130 |
Why?
|
Cocaine-Related Disorders | 1 | 1999 | 461 | 0.130 |
Why?
|
Mother-Child Relations | 2 | 1997 | 495 | 0.130 |
Why?
|
Folic Acid | 4 | 2005 | 1323 | 0.130 |
Why?
|
Stress Disorders, Post-Traumatic | 3 | 2007 | 4575 | 0.130 |
Why?
|
History, 20th Century | 3 | 2011 | 2767 | 0.130 |
Why?
|
Hypochondriasis | 1 | 1996 | 93 | 0.130 |
Why?
|
Sertraline | 6 | 2000 | 209 | 0.130 |
Why?
|
Randomized Controlled Trials as Topic | 4 | 2013 | 10212 | 0.130 |
Why?
|
Aged | 68 | 2015 | 169310 | 0.130 |
Why?
|
Combined Modality Therapy | 12 | 2006 | 8527 | 0.130 |
Why?
|
Antipsychotic Agents | 5 | 2004 | 3067 | 0.130 |
Why?
|
Attitude | 3 | 1999 | 775 | 0.120 |
Why?
|
Research | 1 | 2004 | 1982 | 0.120 |
Why?
|
Lung Diseases | 2 | 1996 | 1909 | 0.120 |
Why?
|
Microtubules | 1 | 2000 | 1074 | 0.120 |
Why?
|
Complementary Therapies | 1 | 1999 | 486 | 0.120 |
Why?
|
Phototherapy | 2 | 1995 | 368 | 0.120 |
Why?
|
Progesterone Congeners | 1 | 1994 | 44 | 0.120 |
Why?
|
Estrogens, Conjugated (USP) | 1 | 1995 | 276 | 0.120 |
Why?
|
Endpoint Determination | 2 | 2008 | 590 | 0.120 |
Why?
|
Self Concept | 2 | 1997 | 1045 | 0.110 |
Why?
|
Drug Resistance | 7 | 2004 | 1596 | 0.110 |
Why?
|
Behavior, Addictive | 1 | 1999 | 462 | 0.110 |
Why?
|
Electric Stimulation Therapy | 1 | 2000 | 628 | 0.110 |
Why?
|
Obstetric Labor Complications | 1 | 1996 | 236 | 0.110 |
Why?
|
Mental Health Services | 2 | 2003 | 1730 | 0.110 |
Why?
|
Adolescent Medicine | 1 | 2014 | 73 | 0.110 |
Why?
|
Caffeine | 2 | 1996 | 700 | 0.110 |
Why?
|
Socioeconomic Factors | 5 | 2005 | 7828 | 0.110 |
Why?
|
Thinking | 1 | 1996 | 320 | 0.110 |
Why?
|
Anticonvulsants | 2 | 2001 | 1906 | 0.110 |
Why?
|
Hyperthyroidism | 1 | 1995 | 294 | 0.110 |
Why?
|
Corticotropin-Releasing Hormone | 2 | 2005 | 361 | 0.110 |
Why?
|
Psychotic Disorders | 6 | 2015 | 3223 | 0.100 |
Why?
|
Accident Proneness | 1 | 1992 | 4 | 0.100 |
Why?
|
Abnormalities, Drug-Induced | 3 | 1997 | 339 | 0.100 |
Why?
|
Protein Processing, Post-Translational | 1 | 2000 | 1974 | 0.100 |
Why?
|
Risk | 6 | 2012 | 9610 | 0.100 |
Why?
|
Thyroid Hormones | 1 | 1995 | 404 | 0.100 |
Why?
|
Risk Management | 2 | 1993 | 558 | 0.100 |
Why?
|
Accidents | 1 | 1993 | 165 | 0.100 |
Why?
|
Biomedical Research | 2 | 2008 | 3429 | 0.100 |
Why?
|
Nicotine | 1 | 1996 | 680 | 0.100 |
Why?
|
Odds Ratio | 5 | 2007 | 9647 | 0.090 |
Why?
|
Plant Extracts | 2 | 2005 | 497 | 0.090 |
Why?
|
Risk Assessment | 5 | 2020 | 23996 | 0.090 |
Why?
|
Auditory Perception | 2 | 1996 | 583 | 0.090 |
Why?
|
Half-Life | 4 | 1998 | 651 | 0.090 |
Why?
|
Chi-Square Distribution | 5 | 2002 | 3415 | 0.090 |
Why?
|
Prospective Studies | 21 | 2008 | 54423 | 0.090 |
Why?
|
Menstrual Cycle | 1 | 1994 | 539 | 0.090 |
Why?
|
Research Personnel | 2 | 2008 | 588 | 0.090 |
Why?
|
Psychotherapy, Group | 1 | 1994 | 413 | 0.090 |
Why?
|
Ethanol | 1 | 1996 | 1324 | 0.090 |
Why?
|
Social Behavior Disorders | 2 | 2003 | 96 | 0.090 |
Why?
|
Pregnancy | 14 | 2004 | 29890 | 0.090 |
Why?
|
Organ Size | 1 | 2015 | 2254 | 0.090 |
Why?
|
Hypothyroidism | 1 | 1995 | 668 | 0.090 |
Why?
|
Heroin Dependence | 1 | 1991 | 172 | 0.090 |
Why?
|
Lithium Carbonate | 7 | 2004 | 179 | 0.080 |
Why?
|
Psychometrics | 8 | 2010 | 3065 | 0.080 |
Why?
|
Wounds and Injuries | 2 | 1993 | 2492 | 0.080 |
Why?
|
Renal Insufficiency | 1 | 2015 | 809 | 0.080 |
Why?
|
Ethics, Research | 2 | 2008 | 176 | 0.080 |
Why?
|
Genetic Predisposition to Disease | 8 | 2008 | 17904 | 0.080 |
Why?
|
Dexamethasone | 3 | 1993 | 1948 | 0.080 |
Why?
|
Data Interpretation, Statistical | 2 | 2010 | 2691 | 0.080 |
Why?
|
Independent Living | 1 | 2013 | 579 | 0.080 |
Why?
|
Infant | 11 | 2008 | 36193 | 0.080 |
Why?
|
Central Nervous System Stimulants | 1 | 1998 | 1177 | 0.080 |
Why?
|
Prognosis | 12 | 2007 | 29629 | 0.080 |
Why?
|
Buspirone | 1 | 1989 | 81 | 0.080 |
Why?
|
Long-Term Care | 4 | 2002 | 633 | 0.080 |
Why?
|
Estrogens | 1 | 1995 | 1522 | 0.080 |
Why?
|
Clomipramine | 3 | 1993 | 54 | 0.080 |
Why?
|
Serotonin | 4 | 2003 | 1041 | 0.080 |
Why?
|
Cholesterol | 3 | 2004 | 2905 | 0.080 |
Why?
|
Case-Control Studies | 9 | 2014 | 22176 | 0.080 |
Why?
|
Choline | 3 | 1999 | 515 | 0.080 |
Why?
|
Animal Experimentation | 1 | 2008 | 46 | 0.080 |
Why?
|
Single-Blind Method | 4 | 2013 | 1574 | 0.080 |
Why?
|
RGS Proteins | 1 | 2008 | 74 | 0.070 |
Why?
|
Adrenergic beta-Antagonists | 1 | 1994 | 1241 | 0.070 |
Why?
|
Ejaculation | 1 | 1988 | 59 | 0.070 |
Why?
|
Psychotherapy | 3 | 1996 | 1647 | 0.070 |
Why?
|
Gastroenterology | 1 | 2014 | 577 | 0.070 |
Why?
|
Sex Factors | 7 | 2005 | 10554 | 0.070 |
Why?
|
Antimanic Agents | 3 | 2002 | 520 | 0.070 |
Why?
|
Circadian Rhythm | 2 | 2000 | 2576 | 0.070 |
Why?
|
Family | 3 | 1994 | 3195 | 0.070 |
Why?
|
Social Behavior | 4 | 2004 | 1135 | 0.070 |
Why?
|
Suicide | 4 | 1999 | 1602 | 0.070 |
Why?
|
Drug Synergism | 3 | 2002 | 1757 | 0.070 |
Why?
|
Reference Values | 3 | 2006 | 4920 | 0.070 |
Why?
|
Verapamil | 1 | 1987 | 242 | 0.070 |
Why?
|
Avoidance Learning | 1 | 2008 | 248 | 0.070 |
Why?
|
Logistic Models | 4 | 2008 | 13255 | 0.070 |
Why?
|
Interview, Psychological | 2 | 2005 | 809 | 0.070 |
Why?
|
Physician's Role | 2 | 2007 | 917 | 0.070 |
Why?
|
Diagnosis, Differential | 11 | 1999 | 12973 | 0.070 |
Why?
|
Somatoform Disorders | 2 | 2002 | 423 | 0.070 |
Why?
|
Family Conflict | 1 | 2007 | 95 | 0.070 |
Why?
|
Statistics as Topic | 3 | 2006 | 2358 | 0.070 |
Why?
|
Psychopathology | 2 | 2012 | 432 | 0.070 |
Why?
|
Sensation | 1 | 1988 | 337 | 0.060 |
Why?
|
Appetite | 3 | 1999 | 247 | 0.060 |
Why?
|
Amygdala | 1 | 2014 | 1354 | 0.060 |
Why?
|
Receptors, GABA-A | 1 | 1990 | 623 | 0.060 |
Why?
|
Cyclic AMP Response Element-Binding Protein | 1 | 2008 | 502 | 0.060 |
Why?
|
Hospitalization | 4 | 1999 | 10721 | 0.060 |
Why?
|
Polymorphism, Single Nucleotide | 6 | 2014 | 15936 | 0.060 |
Why?
|
Drug Interactions | 3 | 2004 | 1416 | 0.060 |
Why?
|
Stereotyping | 1 | 2007 | 239 | 0.060 |
Why?
|
Secondary Prevention | 5 | 2006 | 1475 | 0.060 |
Why?
|
Basal Ganglia | 2 | 1999 | 554 | 0.060 |
Why?
|
Terrorism | 1 | 2008 | 211 | 0.060 |
Why?
|
Behavior Therapy | 4 | 1993 | 879 | 0.060 |
Why?
|
Piperazines | 3 | 2004 | 2523 | 0.060 |
Why?
|
Terminology as Topic | 4 | 2001 | 1530 | 0.060 |
Why?
|
Patient Advocacy | 1 | 2007 | 360 | 0.060 |
Why?
|
Memory | 1 | 1994 | 2193 | 0.060 |
Why?
|
History, 21st Century | 1 | 2011 | 1567 | 0.060 |
Why?
|
Dichotic Listening Tests | 2 | 1996 | 22 | 0.060 |
Why?
|
Body Weight | 6 | 2004 | 4618 | 0.060 |
Why?
|
Affect | 2 | 2010 | 1486 | 0.060 |
Why?
|
Facial Expression | 1 | 2008 | 508 | 0.060 |
Why?
|
Regression Analysis | 3 | 2006 | 6345 | 0.060 |
Why?
|
Home Care Services | 1 | 1991 | 648 | 0.060 |
Why?
|
Inpatients | 2 | 1993 | 2548 | 0.060 |
Why?
|
Time Factors | 14 | 2014 | 39969 | 0.060 |
Why?
|
Conflict of Interest | 1 | 2009 | 554 | 0.060 |
Why?
|
Adaptation, Psychological | 1 | 1995 | 2629 | 0.060 |
Why?
|
Survival Analysis | 7 | 2002 | 10090 | 0.060 |
Why?
|
Drug Therapy | 1 | 2007 | 503 | 0.060 |
Why?
|
Administration, Oral | 5 | 1995 | 4021 | 0.050 |
Why?
|
Assertiveness | 2 | 1994 | 18 | 0.050 |
Why?
|
Nortriptyline | 1 | 2003 | 79 | 0.050 |
Why?
|
Selection Bias | 1 | 2004 | 359 | 0.050 |
Why?
|
Internship and Residency | 1 | 2003 | 5882 | 0.050 |
Why?
|
Internal-External Control | 2 | 2002 | 358 | 0.050 |
Why?
|
Attitude of Health Personnel | 2 | 2008 | 3889 | 0.050 |
Why?
|
Cognition | 3 | 1995 | 6992 | 0.050 |
Why?
|
Human Experimentation | 1 | 2003 | 123 | 0.050 |
Why?
|
Pattern Recognition, Visual | 1 | 2008 | 823 | 0.050 |
Why?
|
Drug Industry | 1 | 2009 | 788 | 0.050 |
Why?
|
Goals | 1 | 2007 | 711 | 0.050 |
Why?
|
Benzothiazoles | 2 | 2000 | 247 | 0.050 |
Why?
|
Disease Susceptibility | 3 | 2000 | 1787 | 0.050 |
Why?
|
Ethics | 1 | 2002 | 94 | 0.050 |
Why?
|
Fathers | 1 | 2005 | 376 | 0.050 |
Why?
|
Stress, Psychological | 2 | 1996 | 4481 | 0.050 |
Why?
|
Age Distribution | 2 | 2000 | 2879 | 0.050 |
Why?
|
Placebo Effect | 4 | 2002 | 518 | 0.050 |
Why?
|
Pregnancy Trimester, Third | 2 | 1994 | 583 | 0.050 |
Why?
|
Libido | 1 | 2002 | 119 | 0.050 |
Why?
|
Biological Science Disciplines | 1 | 2001 | 57 | 0.050 |
Why?
|
Pain, Intractable | 1 | 1982 | 132 | 0.050 |
Why?
|
Interpersonal Relations | 2 | 2007 | 1436 | 0.050 |
Why?
|
Tetrahymena | 1 | 2000 | 10 | 0.050 |
Why?
|
Coronary Disease | 1 | 1996 | 5914 | 0.050 |
Why?
|
Urinary Incontinence | 1 | 1985 | 489 | 0.050 |
Why?
|
Primary Health Care | 1 | 1998 | 4687 | 0.050 |
Why?
|
Apgar Score | 1 | 2001 | 126 | 0.050 |
Why?
|
Informed Consent | 1 | 2007 | 1008 | 0.050 |
Why?
|
Brain | 6 | 2008 | 27121 | 0.050 |
Why?
|
Drug Discovery | 1 | 2008 | 1051 | 0.040 |
Why?
|
Predictive Value of Tests | 3 | 2007 | 15266 | 0.040 |
Why?
|
Retrospective Studies | 17 | 2007 | 80647 | 0.040 |
Why?
|
Massachusetts | 5 | 2004 | 8833 | 0.040 |
Why?
|
Molecular Motor Proteins | 1 | 2000 | 106 | 0.040 |
Why?
|
Arginine Vasopressin | 1 | 2000 | 125 | 0.040 |
Why?
|
Glutamate Decarboxylase | 1 | 2001 | 239 | 0.040 |
Why?
|
Health Care Surveys | 2 | 2014 | 2426 | 0.040 |
Why?
|
Genotype | 5 | 2008 | 12990 | 0.040 |
Why?
|
Executive Function | 1 | 2009 | 1392 | 0.040 |
Why?
|
Water Intoxication | 1 | 1979 | 10 | 0.040 |
Why?
|
Magnetic Resonance Spectroscopy | 5 | 1999 | 3769 | 0.040 |
Why?
|
Fluvoxamine | 1 | 1999 | 78 | 0.040 |
Why?
|
Guideline Adherence | 1 | 2010 | 2220 | 0.040 |
Why?
|
Causality | 1 | 2006 | 1242 | 0.040 |
Why?
|
L-Selectin | 1 | 2000 | 209 | 0.040 |
Why?
|
Choice Behavior | 2 | 2008 | 825 | 0.040 |
Why?
|
Benzophenones | 1 | 1999 | 58 | 0.040 |
Why?
|
Career Mobility | 1 | 2001 | 259 | 0.040 |
Why?
|
Cross-Sectional Studies | 5 | 2012 | 26129 | 0.040 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2014 | 2422 | 0.040 |
Why?
|
Cohort Studies | 8 | 2006 | 41495 | 0.040 |
Why?
|
Hospitals | 1 | 1993 | 3883 | 0.040 |
Why?
|
Sleep | 5 | 1996 | 4768 | 0.040 |
Why?
|
Diagnosis, Dual (Psychiatry) | 1 | 1999 | 303 | 0.040 |
Why?
|
Parent-Child Relations | 1 | 2004 | 761 | 0.040 |
Why?
|
Tryptophan | 1 | 2001 | 482 | 0.040 |
Why?
|
Pediatrics | 1 | 2014 | 3589 | 0.040 |
Why?
|
Family Characteristics | 1 | 2004 | 1004 | 0.040 |
Why?
|
Hypotension, Orthostatic | 3 | 1987 | 258 | 0.040 |
Why?
|
Drug Tolerance | 1 | 2000 | 367 | 0.040 |
Why?
|
Dominance, Cerebral | 2 | 2008 | 623 | 0.040 |
Why?
|
Psychiatric Department, Hospital | 1 | 1999 | 126 | 0.040 |
Why?
|
Neurotransmitter Agents | 2 | 2000 | 665 | 0.040 |
Why?
|
Erectile Dysfunction | 1 | 2002 | 444 | 0.040 |
Why?
|
Adrenocorticotropic Hormone | 1 | 2000 | 618 | 0.040 |
Why?
|
Decision Trees | 1 | 2000 | 504 | 0.040 |
Why?
|
Pemoline | 1 | 1998 | 18 | 0.040 |
Why?
|
Health Status | 2 | 2004 | 4077 | 0.040 |
Why?
|
Magnetic Resonance Imaging | 5 | 2015 | 36426 | 0.040 |
Why?
|
Lung Diseases, Obstructive | 2 | 1996 | 308 | 0.040 |
Why?
|
Statistics, Nonparametric | 2 | 2003 | 2850 | 0.040 |
Why?
|
Multicenter Studies as Topic | 1 | 2003 | 1702 | 0.040 |
Why?
|
Entrepreneurship | 1 | 1998 | 23 | 0.040 |
Why?
|
Electronic Health Records | 1 | 2015 | 4811 | 0.040 |
Why?
|
Factor Analysis, Statistical | 1 | 2000 | 999 | 0.040 |
Why?
|
Observer Variation | 1 | 2004 | 2606 | 0.040 |
Why?
|
Membrane Transport Proteins | 1 | 2003 | 1035 | 0.040 |
Why?
|
Sensitivity and Specificity | 3 | 2004 | 14665 | 0.040 |
Why?
|
Outpatients | 4 | 2004 | 1597 | 0.040 |
Why?
|
Labor, Obstetric | 1 | 2001 | 323 | 0.040 |
Why?
|
Phenelzine | 2 | 1988 | 28 | 0.040 |
Why?
|
Attitude to Health | 2 | 2005 | 2025 | 0.040 |
Why?
|
Patient Care Planning | 1 | 2003 | 909 | 0.040 |
Why?
|
Triazines | 1 | 1999 | 311 | 0.040 |
Why?
|
Capitation Fee | 1 | 1998 | 116 | 0.040 |
Why?
|
Creatine | 1 | 1999 | 427 | 0.040 |
Why?
|
Disease Progression | 4 | 2010 | 13510 | 0.040 |
Why?
|
Headache | 3 | 1999 | 1256 | 0.030 |
Why?
|
Confidence Intervals | 2 | 2000 | 2927 | 0.030 |
Why?
|
Histrionic Personality Disorder | 1 | 1996 | 10 | 0.030 |
Why?
|
Problem Solving | 1 | 1999 | 443 | 0.030 |
Why?
|
Social Support | 1 | 2007 | 2172 | 0.030 |
Why?
|
Delayed-Action Preparations | 2 | 1997 | 962 | 0.030 |
Why?
|
Linkage Disequilibrium | 3 | 2008 | 1998 | 0.030 |
Why?
|
Citalopram | 3 | 2005 | 402 | 0.030 |
Why?
|
Boston | 2 | 2007 | 9327 | 0.030 |
Why?
|
Cytosol | 1 | 1999 | 888 | 0.030 |
Why?
|
Nerve Net | 1 | 2008 | 2291 | 0.030 |
Why?
|
Sleep Initiation and Maintenance Disorders | 4 | 2003 | 1081 | 0.030 |
Why?
|
Young Adult | 4 | 2021 | 59260 | 0.030 |
Why?
|
Behavioral Sciences | 1 | 1996 | 29 | 0.030 |
Why?
|
Physicians | 1 | 2014 | 4591 | 0.030 |
Why?
|
Health Services Research | 1 | 2003 | 1812 | 0.030 |
Why?
|
Fascioliasis | 3 | 1969 | 14 | 0.030 |
Why?
|
Sampling Studies | 1 | 1997 | 615 | 0.030 |
Why?
|
Delivery of Health Care | 1 | 2013 | 5337 | 0.030 |
Why?
|
Compulsive Personality Disorder | 1 | 1995 | 48 | 0.030 |
Why?
|
Career Choice | 1 | 2001 | 756 | 0.030 |
Why?
|
Drug Prescriptions | 2 | 2002 | 1670 | 0.030 |
Why?
|
Proportional Hazards Models | 4 | 2003 | 12463 | 0.030 |
Why?
|
Chronic Disease | 6 | 2004 | 9319 | 0.030 |
Why?
|
Treatment Failure | 2 | 2003 | 2643 | 0.030 |
Why?
|
Treatment Refusal | 2 | 1997 | 429 | 0.030 |
Why?
|
Health Maintenance Organizations | 1 | 1998 | 659 | 0.030 |
Why?
|
Narcissism | 1 | 1995 | 64 | 0.030 |
Why?
|
Culture | 1 | 1999 | 623 | 0.030 |
Why?
|
Amines | 2 | 1967 | 281 | 0.030 |
Why?
|
Clinical Protocols | 3 | 2006 | 1440 | 0.030 |
Why?
|
Models, Animal | 1 | 2001 | 2112 | 0.030 |
Why?
|
Personality Tests | 2 | 1991 | 81 | 0.030 |
Why?
|
Serotonin Plasma Membrane Transport Proteins | 2 | 2008 | 324 | 0.030 |
Why?
|
Educational Status | 1 | 2002 | 2522 | 0.030 |
Why?
|
Neurologic Examination | 1 | 1997 | 916 | 0.030 |
Why?
|
Infant, Newborn | 5 | 2001 | 26202 | 0.030 |
Why?
|
Thyroid Function Tests | 1 | 1995 | 288 | 0.030 |
Why?
|
Mental Status Schedule | 1 | 1995 | 315 | 0.030 |
Why?
|
Algorithms | 1 | 1995 | 14033 | 0.030 |
Why?
|
Metabolic Clearance Rate | 1 | 1994 | 361 | 0.030 |
Why?
|
Rage | 1 | 1993 | 30 | 0.030 |
Why?
|
Antisocial Personality Disorder | 1 | 1995 | 224 | 0.030 |
Why?
|
Syndrome | 3 | 1997 | 3267 | 0.030 |
Why?
|
Propranolol | 2 | 1986 | 489 | 0.030 |
Why?
|
Bulimia | 1 | 1996 | 400 | 0.030 |
Why?
|
Condoms | 1 | 1996 | 331 | 0.030 |
Why?
|
Models, Psychological | 2 | 1996 | 829 | 0.030 |
Why?
|
Triiodothyronine | 1 | 1995 | 493 | 0.030 |
Why?
|
Polymorphism, Genetic | 1 | 2003 | 4243 | 0.030 |
Why?
|
Membrane Glycoproteins | 1 | 2003 | 3701 | 0.030 |
Why?
|
Phenotype | 6 | 2008 | 16592 | 0.030 |
Why?
|
Fee-for-Service Plans | 1 | 1998 | 700 | 0.030 |
Why?
|
Awareness | 1 | 1997 | 648 | 0.030 |
Why?
|
Blood Pressure | 3 | 1999 | 8481 | 0.030 |
Why?
|
Ethics, Medical | 1 | 1998 | 783 | 0.030 |
Why?
|
Models, Statistical | 2 | 2004 | 5079 | 0.030 |
Why?
|
Pregnanes | 1 | 1972 | 7 | 0.030 |
Why?
|
Electroconvulsive Therapy | 1 | 1998 | 500 | 0.030 |
Why?
|
Fatigue | 1 | 1999 | 1552 | 0.020 |
Why?
|
Professional Practice | 1 | 2014 | 313 | 0.020 |
Why?
|
Gene Frequency | 3 | 2005 | 3606 | 0.020 |
Why?
|
Aging | 2 | 2007 | 8710 | 0.020 |
Why?
|
Accident Prevention | 1 | 1992 | 76 | 0.020 |
Why?
|
Hypertension | 5 | 2015 | 8540 | 0.020 |
Why?
|
Infant, Newborn, Diseases | 1 | 1997 | 589 | 0.020 |
Why?
|
Thyroxine | 1 | 1995 | 666 | 0.020 |
Why?
|
Pregnancy Trimester, Second | 1 | 1994 | 731 | 0.020 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2008 | 9001 | 0.020 |
Why?
|
Data Collection | 2 | 2001 | 3322 | 0.020 |
Why?
|
Chromosome Mapping | 3 | 2005 | 4615 | 0.020 |
Why?
|
Respiratory Function Tests | 1 | 1996 | 1682 | 0.020 |
Why?
|
Infusions, Intravenous | 1 | 1995 | 2217 | 0.020 |
Why?
|
Nerve Tissue Proteins | 1 | 2003 | 4415 | 0.020 |
Why?
|
Airway Obstruction | 1 | 1996 | 661 | 0.020 |
Why?
|
Respiratory Tract Diseases | 1 | 1996 | 750 | 0.020 |
Why?
|
Patient Transfer | 1 | 1998 | 794 | 0.020 |
Why?
|
Australia | 1 | 2014 | 1250 | 0.020 |
Why?
|
Carrier Proteins | 1 | 2003 | 4937 | 0.020 |
Why?
|
Psychomotor Performance | 2 | 2009 | 1882 | 0.020 |
Why?
|
Chest Pain | 1 | 1997 | 1091 | 0.020 |
Why?
|
Pregnancy Trimester, First | 1 | 1994 | 907 | 0.020 |
Why?
|
Self Efficacy | 1 | 2014 | 638 | 0.020 |
Why?
|
Patient Education as Topic | 2 | 2014 | 2319 | 0.020 |
Why?
|
Pyrrolidines | 1 | 1972 | 338 | 0.020 |
Why?
|
Brain Chemistry | 1 | 1993 | 960 | 0.020 |
Why?
|
Trazodone | 1 | 1989 | 68 | 0.020 |
Why?
|
Xerostomia | 2 | 1987 | 94 | 0.020 |
Why?
|
Functional Laterality | 1 | 1996 | 2257 | 0.020 |
Why?
|
Drug Costs | 1 | 1998 | 1183 | 0.020 |
Why?
|
Motivation | 1 | 1999 | 2006 | 0.020 |
Why?
|
Curriculum | 1 | 2003 | 3743 | 0.020 |
Why?
|
Postpartum Period | 1 | 1996 | 1175 | 0.020 |
Why?
|
Outpatient Clinics, Hospital | 1 | 1991 | 395 | 0.020 |
Why?
|
Alleles | 3 | 2008 | 6864 | 0.020 |
Why?
|
Receptors, Dopamine | 1 | 1990 | 296 | 0.020 |
Why?
|
Stroop Test | 1 | 2009 | 71 | 0.020 |
Why?
|
Therapeutic Equivalency | 1 | 1989 | 134 | 0.020 |
Why?
|
Patient Compliance | 3 | 1997 | 2690 | 0.020 |
Why?
|
Glomerular Filtration Rate | 2 | 2015 | 2178 | 0.020 |
Why?
|
Animal Rights | 1 | 2008 | 10 | 0.020 |
Why?
|
Incidence | 4 | 2007 | 21355 | 0.020 |
Why?
|
Diazepam | 1 | 1989 | 215 | 0.020 |
Why?
|
Nitrophenols | 3 | 1999 | 169 | 0.020 |
Why?
|
Methadone | 1 | 1991 | 321 | 0.020 |
Why?
|
Interdisciplinary Communication | 1 | 2014 | 931 | 0.020 |
Why?
|
Protein Binding | 1 | 2000 | 9353 | 0.020 |
Why?
|
Light | 1 | 1994 | 1353 | 0.020 |
Why?
|
Drug Monitoring | 1 | 1994 | 962 | 0.020 |
Why?
|
Dehydroepiandrosterone | 1 | 1989 | 258 | 0.020 |
Why?
|
Abruptio Placentae | 1 | 1989 | 118 | 0.020 |
Why?
|
Safety | 1 | 1993 | 1149 | 0.020 |
Why?
|
Control Groups | 1 | 2008 | 104 | 0.020 |
Why?
|
United States | 4 | 2011 | 72340 | 0.020 |
Why?
|
Nausea | 3 | 1999 | 679 | 0.020 |
Why?
|
ROC Curve | 1 | 2015 | 3578 | 0.020 |
Why?
|
Likelihood Functions | 1 | 2010 | 992 | 0.020 |
Why?
|
Morbidity | 1 | 1993 | 1752 | 0.020 |
Why?
|
Dothiepin | 1 | 1986 | 1 | 0.020 |
Why?
|
Reproducibility of Results | 4 | 2002 | 20100 | 0.020 |
Why?
|
Dibenzothiepins | 1 | 1986 | 8 | 0.020 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2000 | 4369 | 0.020 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 1996 | 2199 | 0.020 |
Why?
|
Crime | 1 | 2008 | 203 | 0.020 |
Why?
|
Cluster Analysis | 1 | 1994 | 2707 | 0.020 |
Why?
|
Random Allocation | 5 | 1989 | 2395 | 0.020 |
Why?
|
Mental Processes | 1 | 2008 | 244 | 0.020 |
Why?
|
Speech Perception | 1 | 1991 | 509 | 0.020 |
Why?
|
Verbal Learning | 1 | 2009 | 463 | 0.020 |
Why?
|
Professional-Patient Relations | 1 | 1992 | 726 | 0.020 |
Why?
|
Acute Disease | 2 | 1987 | 7237 | 0.020 |
Why?
|
Body Mass Index | 3 | 2004 | 12953 | 0.020 |
Why?
|
Health Services Needs and Demand | 1 | 2014 | 1403 | 0.020 |
Why?
|
Substance Abuse, Intravenous | 1 | 1991 | 529 | 0.020 |
Why?
|
Genetic Markers | 2 | 2003 | 2601 | 0.020 |
Why?
|
Mandelic Acids | 1 | 1985 | 46 | 0.020 |
Why?
|
Tremor | 1 | 1987 | 191 | 0.020 |
Why?
|
Phenols | 1 | 1969 | 517 | 0.020 |
Why?
|
Urination Disorders | 1 | 1987 | 238 | 0.020 |
Why?
|
Primates | 1 | 2008 | 523 | 0.020 |
Why?
|
Linear Models | 1 | 2015 | 5872 | 0.020 |
Why?
|
Dihydrotestosterone | 1 | 1966 | 195 | 0.020 |
Why?
|
Constipation | 2 | 1987 | 563 | 0.020 |
Why?
|
Health Personnel | 1 | 1999 | 3335 | 0.020 |
Why?
|
Practice Guidelines as Topic | 2 | 2003 | 7391 | 0.020 |
Why?
|
Amitriptyline | 1 | 1985 | 112 | 0.010 |
Why?
|
Dizziness | 2 | 1998 | 259 | 0.010 |
Why?
|
Cholinesterase Inhibitors | 1 | 1986 | 242 | 0.010 |
Why?
|
Health Care Costs | 1 | 1998 | 3242 | 0.010 |
Why?
|
Chemistry | 3 | 1972 | 347 | 0.010 |
Why?
|
Genetic Association Studies | 1 | 2014 | 2735 | 0.010 |
Why?
|
Chemical Phenomena | 3 | 1972 | 507 | 0.010 |
Why?
|
Connective Tissue Diseases | 1 | 1987 | 285 | 0.010 |
Why?
|
Serotonin 5-HT1 Receptor Agonists | 1 | 2004 | 42 | 0.010 |
Why?
|
Dangerous Behavior | 1 | 1984 | 65 | 0.010 |
Why?
|
Sleep Stages | 2 | 1999 | 694 | 0.010 |
Why?
|
Education, Medical, Graduate | 1 | 1996 | 2373 | 0.010 |
Why?
|
Calcium Channel Blockers | 1 | 1987 | 694 | 0.010 |
Why?
|
Radioimmunoassay | 2 | 1996 | 861 | 0.010 |
Why?
|
Alcohol Drinking | 1 | 1996 | 4028 | 0.010 |
Why?
|
Health Promotion | 1 | 1996 | 2214 | 0.010 |
Why?
|
Neuropsychological Tests | 2 | 2009 | 7054 | 0.010 |
Why?
|
von Willebrand Factor | 1 | 1987 | 673 | 0.010 |
Why?
|
Drug Combinations | 1 | 1989 | 2048 | 0.010 |
Why?
|
Affective Disorders, Psychotic | 1 | 1984 | 186 | 0.010 |
Why?
|
Quality of Health Care | 1 | 1998 | 4331 | 0.010 |
Why?
|
Hospitals, Psychiatric | 1 | 1984 | 321 | 0.010 |
Why?
|
Mental Recall | 1 | 2009 | 1221 | 0.010 |
Why?
|
Juvenile Delinquency | 1 | 2003 | 117 | 0.010 |
Why?
|
Reaction Time | 1 | 2009 | 2089 | 0.010 |
Why?
|
Obesity | 1 | 2004 | 12947 | 0.010 |
Why?
|
Models, Theoretical | 1 | 2014 | 3575 | 0.010 |
Why?
|
Coffee | 1 | 1986 | 593 | 0.010 |
Why?
|
Caregivers | 1 | 2014 | 2238 | 0.010 |
Why?
|
Memory, Short-Term | 1 | 2008 | 982 | 0.010 |
Why?
|
Steroids | 1 | 1967 | 929 | 0.010 |
Why?
|
Muscle, Smooth | 1 | 1985 | 926 | 0.010 |
Why?
|
Achievement | 1 | 2003 | 288 | 0.010 |
Why?
|
Competitive Behavior | 1 | 2001 | 78 | 0.010 |
Why?
|
Education, Graduate | 1 | 2001 | 75 | 0.010 |
Why?
|
Psychomotor Agitation | 1 | 2003 | 305 | 0.010 |
Why?
|
Financial Support | 1 | 2001 | 117 | 0.010 |
Why?
|
Enkephalins | 1 | 2001 | 139 | 0.010 |
Why?
|
Receptors, Purinergic P1 | 1 | 2001 | 108 | 0.010 |
Why?
|
Physician-Patient Relations | 1 | 2014 | 3251 | 0.010 |
Why?
|
Receptor, Adenosine A2A | 1 | 2001 | 128 | 0.010 |
Why?
|
Sample Size | 1 | 2004 | 841 | 0.010 |
Why?
|
Lod Score | 1 | 2001 | 600 | 0.010 |
Why?
|
Infant Behavior | 1 | 2001 | 156 | 0.010 |
Why?
|
Nuclear Family | 1 | 2001 | 311 | 0.010 |
Why?
|
Communication | 1 | 2014 | 3875 | 0.010 |
Why?
|
Animals | 7 | 2008 | 168475 | 0.010 |
Why?
|
Chromosomes, Human, Pair 12 | 1 | 2001 | 430 | 0.010 |
Why?
|
Conduct Disorder | 1 | 2001 | 245 | 0.010 |
Why?
|
Salaries and Fringe Benefits | 1 | 2001 | 257 | 0.010 |
Why?
|
Vision Disorders | 1 | 1987 | 1088 | 0.010 |
Why?
|
Urinary Bladder | 1 | 1985 | 1152 | 0.010 |
Why?
|
Inappropriate ADH Syndrome | 1 | 1979 | 61 | 0.010 |
Why?
|
Kidney | 2 | 1987 | 7048 | 0.010 |
Why?
|
Demography | 1 | 2003 | 1648 | 0.010 |
Why?
|
Chromosomes, Human, Pair 1 | 1 | 2001 | 638 | 0.010 |
Why?
|
Inositol | 1 | 1999 | 215 | 0.010 |
Why?
|
Schizophrenia | 2 | 2015 | 6937 | 0.010 |
Why?
|
Brain Mapping | 1 | 2014 | 6635 | 0.010 |
Why?
|
Behavior | 1 | 2001 | 541 | 0.010 |
Why?
|
Caudate Nucleus | 1 | 1999 | 390 | 0.010 |
Why?
|
Quantitative Trait, Heritable | 1 | 2001 | 543 | 0.010 |
Why?
|
Lymphocyte Count | 1 | 2000 | 778 | 0.010 |
Why?
|
Research Support as Topic | 1 | 2001 | 697 | 0.010 |
Why?
|
Emergency Service, Hospital | 2 | 1997 | 7879 | 0.010 |
Why?
|
Professional Competence | 1 | 2000 | 431 | 0.010 |
Why?
|
Diabetes Mellitus | 1 | 2015 | 5841 | 0.010 |
Why?
|
Protein Precursors | 1 | 2001 | 1132 | 0.010 |
Why?
|
Schizophrenic Psychology | 1 | 1984 | 1647 | 0.010 |
Why?
|
Mass Screening | 1 | 2012 | 5429 | 0.010 |
Why?
|
Oxygen | 1 | 2008 | 4227 | 0.010 |
Why?
|
Hyponatremia | 1 | 1979 | 279 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2003 | 4576 | 0.010 |
Why?
|
Universities | 1 | 2001 | 993 | 0.010 |
Why?
|
Folic Acid Deficiency | 1 | 1997 | 117 | 0.010 |
Why?
|
Mutation | 1 | 2000 | 30053 | 0.010 |
Why?
|
Emotions | 1 | 2008 | 2739 | 0.010 |
Why?
|
Vitamin B 12 Deficiency | 1 | 1997 | 118 | 0.010 |
Why?
|
Receptors, Serotonin | 1 | 1997 | 208 | 0.010 |
Why?
|
Paresthesia | 1 | 1997 | 162 | 0.010 |
Why?
|
Anorexia Nervosa | 1 | 1985 | 1361 | 0.010 |
Why?
|
Genetic Linkage | 1 | 2001 | 2341 | 0.010 |
Why?
|
Fluorescent Antibody Technique | 1 | 2000 | 2467 | 0.010 |
Why?
|
Kidney Concentrating Ability | 2 | 1987 | 34 | 0.010 |
Why?
|
Amino Acids | 1 | 2001 | 1718 | 0.010 |
Why?
|
Immunophenotyping | 1 | 2000 | 1869 | 0.010 |
Why?
|
Publishing | 1 | 2001 | 833 | 0.010 |
Why?
|
Norepinephrine | 1 | 1997 | 897 | 0.010 |
Why?
|
Occupations | 1 | 1996 | 515 | 0.010 |
Why?
|
Calcium | 1 | 1987 | 5722 | 0.010 |
Why?
|
Spectrophotometry, Atomic | 1 | 1993 | 82 | 0.010 |
Why?
|
Hormone Replacement Therapy | 1 | 1999 | 751 | 0.010 |
Why?
|
Models, Structural | 1 | 1993 | 340 | 0.010 |
Why?
|
Pedigree | 1 | 2001 | 4542 | 0.010 |
Why?
|
Fellowships and Scholarships | 1 | 2001 | 1117 | 0.010 |
Why?
|
Behavior, Animal | 1 | 2001 | 1878 | 0.010 |
Why?
|
Frontal Lobe | 1 | 1999 | 1420 | 0.010 |
Why?
|
Fluorine | 1 | 1992 | 83 | 0.010 |
Why?
|
Acoustic Stimulation | 1 | 1996 | 1235 | 0.010 |
Why?
|
Lymphocytes | 1 | 2000 | 2612 | 0.010 |
Why?
|
Pattern Recognition, Automated | 1 | 1998 | 997 | 0.010 |
Why?
|
Fractures, Bone | 1 | 1984 | 2046 | 0.010 |
Why?
|
T-Lymphocyte Subsets | 1 | 2000 | 1802 | 0.010 |
Why?
|
Saliva | 1 | 1996 | 828 | 0.010 |
Why?
|
Kidney Diseases | 1 | 1981 | 2091 | 0.010 |
Why?
|
Thiothixene | 1 | 1990 | 3 | 0.010 |
Why?
|
Fasciola hepatica | 1 | 1969 | 15 | 0.010 |
Why?
|
Cost-Benefit Analysis | 1 | 2003 | 5493 | 0.010 |
Why?
|
Employment | 1 | 1996 | 1118 | 0.010 |
Why?
|
Injections, Intravenous | 1 | 1992 | 1379 | 0.010 |
Why?
|
Down-Regulation | 1 | 1997 | 2919 | 0.010 |
Why?
|
Flow Cytometry | 1 | 2000 | 5870 | 0.010 |
Why?
|
Dioxins | 1 | 1969 | 91 | 0.010 |
Why?
|
Weight Gain | 1 | 1999 | 2348 | 0.010 |
Why?
|
Quality of Life | 2 | 2003 | 13367 | 0.000 |
Why?
|
RNA, Messenger | 1 | 2003 | 12794 | 0.000 |
Why?
|
Ataxia | 1 | 1991 | 306 | 0.000 |
Why?
|
Dyspnea | 1 | 1996 | 1347 | 0.000 |
Why?
|
Pituitary-Adrenal System | 1 | 1991 | 552 | 0.000 |
Why?
|
Weight Loss | 1 | 1999 | 2684 | 0.000 |
Why?
|
Social Class | 1 | 1996 | 2004 | 0.000 |
Why?
|
Carbamazepine | 1 | 1988 | 224 | 0.000 |
Why?
|
Hypothalamo-Hypophyseal System | 1 | 1991 | 701 | 0.000 |
Why?
|
Sulfur Compounds | 1 | 1987 | 32 | 0.000 |
Why?
|
Pulse | 1 | 1987 | 217 | 0.000 |
Why?
|
Haloperidol | 1 | 1988 | 389 | 0.000 |
Why?
|
Patient Admission | 1 | 1994 | 1367 | 0.000 |
Why?
|
Anthelmintics | 1 | 1966 | 83 | 0.000 |
Why?
|
Rabbits | 2 | 1969 | 4772 | 0.000 |
Why?
|
Naphthyridines | 1 | 1987 | 143 | 0.000 |
Why?
|
Cats | 1 | 1986 | 975 | 0.000 |
Why?
|
Pregnancy Complications, Cardiovascular | 1 | 1989 | 513 | 0.000 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 1997 | 3359 | 0.000 |
Why?
|
Quinolines | 1 | 1969 | 765 | 0.000 |
Why?
|
Mice | 2 | 2001 | 81539 | 0.000 |
Why?
|
Child Abuse | 1 | 1992 | 1077 | 0.000 |
Why?
|
Diet | 1 | 2001 | 8075 | 0.000 |
Why?
|
Gene Expression Regulation | 1 | 2000 | 11904 | 0.000 |
Why?
|
Creatinine | 1 | 1987 | 1899 | 0.000 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 1987 | 3810 | 0.000 |
Why?
|
Kidney Function Tests | 1 | 1981 | 679 | 0.000 |
Why?
|
Gestational Age | 1 | 1988 | 3577 | 0.000 |
Why?
|
Child Development | 1 | 1990 | 2306 | 0.000 |
Why?
|
Arrhythmias, Cardiac | 1 | 1985 | 2244 | 0.000 |
Why?
|
Aged, 80 and over | 2 | 1988 | 58984 | 0.000 |
Why?
|
Cyanates | 1 | 1969 | 20 | 0.000 |
Why?
|
Sheep | 1 | 1966 | 1440 | 0.000 |
Why?
|
Cattle | 1 | 1966 | 3849 | 0.000 |
Why?
|